Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -15.01%6.79B | -16.71%6.44B | 2.09%7.66B | 6.99%30.67B | 3.40%7.46B | 17.72%7.99B | 8.65%7.73B | -0.77%7.5B | -0.99%28.67B | -17.13%7.21B |
| Cost of revenue | -8.92%6.11B | -7.96%5.76B | 7.73%6.6B | 8.72%25.97B | 10.28%6.88B | 20.68%6.71B | 5.61%6.26B | -0.63%6.13B | 17.78%23.88B | -7.02%6.24B |
| Gross profit | -46.92%680M | -53.84%680M | -23.12%1.05B | -1.65%4.71B | -40.53%581M | 4.32%1.28B | 23.78%1.47B | -1.37%1.37B | -44.85%4.79B | -51.08%977M |
| Operating expense | -55.28%826M | 269.11%1.61B | 62.40%851M | 0.76%2.65B | -122.05%-159M | 196.95%1.85B | -10.45%437M | -34.34%524M | 28.75%2.63B | -47.64%721M |
| Selling and administrative expenses | 3.51%913M | -8.78%842M | -10.19%784M | 11.21%3.67B | 15.89%992M | 2.08%882M | 23.56%923M | 4.80%873M | 27.27%3.3B | -17.05%856M |
| -Selling and marketing expense | -3.32%524M | -5.54%494M | 2.37%519M | 12.49%2.14B | 21.19%572M | 15.32%542M | 11.75%523M | 2.22%507M | 32.73%1.91B | -12.43%472M |
| -General and administrative expense | 14.41%389M | -13.00%348M | -27.60%265M | 9.47%1.53B | 9.38%420M | -13.71%340M | 43.37%400M | 8.61%366M | 20.48%1.39B | -22.11%384M |
| Other operating expenses | -92.01%88M | 1,523.81%1.02B | 291.84%192M | 397.50%199M | ---- | 55,000.00%1.1B | --63M | -31.94%49M | -75.90%40M | -7.88%152M |
| Total other operating income | 27.74%175M | -54.10%252M | -68.59%125M | 71.59%1.22B | 301.05%1.15B | -43.85%137M | 111.97%549M | 271.96%398M | -0.84%711M | 259.44%287M |
| Operating profit | 74.20%-146M | -190.06%-933M | -76.03%203M | -4.59%2.06B | 189.06%740M | -193.40%-566M | 47.58%1.04B | 43.07%847M | -67.50%2.16B | -58.71%256M |
| Net non-operating interest income (expenses) | 11.96%-81M | -193.33%-88M | -104.65%-88M | -87.05%-260M | -115.91%-95M | -178.79%-92M | -36.36%-30M | -7.50%-43M | -110.61%-139M | -37.50%-44M |
| Non-operating interest expense | -11.96%81M | 193.33%88M | 104.65%88M | 142.00%242M | 115.91%95M | 178.79%92M | 36.36%30M | 7.50%43M | 72.41%100M | 83.33%44M |
| Total other finance cost | ---- | ---- | ---- | -53.85%18M | ---- | ---- | ---- | ---- | 387.50%39M | ---- |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -7,000.00%-69M | 59.09%-27M | -2,900.00%-28M | -215.05%-107M | -253.57%-43M | -92.31%1M | -571.43%-66M | -97.37%1M | -43.64%93M | 203.70%28M |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 54.95%-296M | -211.49%-1.05B | -89.19%87M | -19.91%1.69B | 150.83%602M | -212.12%-657M | 35.45%940M | 36.44%805M | -68.66%2.11B | -57.22%240M |
| Income tax | -104.76%-5M | -100.76%-1M | -32.35%69M | 11.39%401M | -35.71%63M | -28.57%105M | 114.75%131M | 88.89%102M | -11.33%360M | 27.27%98M |
| Net income | 61.81%-291M | -229.42%-1.05B | -97.44%18M | -26.34%1.29B | 279.58%539M | -273.58%-762M | 27.80%809M | 31.16%703M | -72.34%1.75B | -70.66%142M |
| Net income continuous operations | 61.81%-291M | -229.42%-1.05B | -97.44%18M | -26.34%1.29B | 279.58%539M | -273.58%-762M | 27.80%809M | 31.16%703M | -72.34%1.75B | -70.66%142M |
| Noncontrolling interests | -107.41%-2M | 6.25%34M | 2.86%36M | 111.11%114M | -33.33%20M | 80.00%27M | 540.00%32M | 775.00%35M | 980.00%54M | 900.00%30M |
| Net income attributable to the company | 63.37%-289M | -239.12%-1.08B | -102.69%-18M | -30.72%1.18B | 363.39%519M | -286.08%-789M | 23.73%777M | 25.56%668M | -73.17%1.7B | -76.72%112M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 63.37%-289M | -239.12%-1.08B | -102.69%-18M | -30.72%1.18B | 363.39%519M | -286.08%-789M | 23.73%777M | 25.56%668M | -73.17%1.7B | -76.72%112M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 60.00%-0.04 | -240.00%-0.14 | 0 | -30.66%0.147 | 500.00%0.06 | -300.00%-0.1 | 25.00%0.1 | 14.29%0.08 | -73.16%0.212 | -83.33%0.01 |
| Diluted earnings per share | 60.00%-0.04 | -240.00%-0.14 | 0 | -30.66%0.147 | 500.00%0.06 | -300.00%-0.1 | 25.00%0.1 | 20.30%0.08 | -73.16%0.212 | -83.33%0.01 |
| Dividend per share | -70.00%0.03 | 0 | -40.00%0.03 | -37.50%0.15 | 0 | 25.00%0.1 | 0 | -68.75%0.05 | -50.00%0.24 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.